{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:27:10Z","timestamp":1768829230060,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"statutory funds of University of Lodz"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12929-017-0388-y","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T11:35:44Z","timestamp":1509363344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Expression of hypoxia inducible factor 1\u03b1 and 2\u03b1 and its association with vitamin C level in thyroid lesions"],"prefix":"10.1186","volume":"24","author":[{"given":"Pawe\u0142","family":"J\u00f3\u017awiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Ciesielski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Zaczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Lipi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lech","family":"Pomorski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Bry\u015b","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Forma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4982-7901","authenticated-orcid":false,"given":"Anna","family":"Krze\u015blak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,30]]},"reference":[{"key":"388_CR1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2008.09.005","volume":"121","author":"V Ganapathy","year":"2009","unstructured":"Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther. 2009;121:29\u201340.","journal-title":"Pharmacol Ther"},{"key":"388_CR2","doi-asserted-by":"crossref","unstructured":"Eales KL, Hollinshead KE, Tennant DA. Hypoxia and metabolic adaptation of cancer cells. Oncogene. 2016;5:\u2013e190.","DOI":"10.1038\/oncsis.2015.50"},{"key":"388_CR3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrc3621","volume":"13","author":"DC Bersten","year":"2013","unstructured":"Bersten DC, Sullivan AE, Peet DJ, Whitelaw ML. bHLH-PAS proteins in cancer. Nat Rev Cancer. 2013;13:827\u201341.","journal-title":"Nat Rev Cancer"},{"key":"388_CR4","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1128\/MCB.22.9.2984-2992.2002","volume":"22","author":"N Sang","year":"2002","unstructured":"Sang N, Fang J, Srinivas V, Leshchinsky I, Caro J. Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300\/CBP. Mol Cell Biol. 2002;22:2984\u201392.","journal-title":"Mol Cell Biol"},{"key":"388_CR5","doi-asserted-by":"crossref","unstructured":"Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005, re12.","DOI":"10.1126\/stke.3062005re12"},{"key":"388_CR6","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","volume":"23","author":"H CJ","year":"2003","unstructured":"CJ H, Wang LY, Chodosh LA, Keith B, Simon MC. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol. 2003;23:9361\u201374.","journal-title":"Mol Cell Biol"},{"key":"388_CR7","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1158\/0008-5472.CAN-04-4130","volume":"65","author":"V Wang","year":"2005","unstructured":"Wang V, Davis DA, Haque M, Huang LE, Yarchoan R. Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells. Cancer Res. 2005;65:3299\u2013306.","journal-title":"Cancer Res"},{"key":"388_CR8","doi-asserted-by":"crossref","first-page":"e108309","DOI":"10.1371\/journal.pone.0108309","volume":"9","author":"R Petruzzelli","year":"2014","unstructured":"Petruzzelli R, Christensen DR, Parry KL, Sanchez-Elsner T, Houghton FD. HIF-2\u03b1 regulates NANOG expression in human embryonic stem cells following hypoxia and reoxygenation through the interaction with an Oct-sox cis regulatory element. PLoS One. 2014;9:e108309.","journal-title":"PLoS One"},{"key":"388_CR9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1667\/RR14016.1","volume":"183","author":"M Zhang","year":"2015","unstructured":"Zhang M, Qiu Q, Li Z, et al. HIF-1 alpha regulates the response of primary sarcomas to radiation therapy through a cell autonomous mechanism. Radiat Res. 2015;183:594\u2013609.","journal-title":"Radiat Res"},{"key":"388_CR10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ctrv.2015.05.004","volume":"41","author":"J Zhao","year":"2015","unstructured":"Zhao J, Du F, Luo Y, Shen G, Zheng F, Xu B. The emerging role of hypoxia-inducible factor-2 involved in chemo\/radioresistance in solid tumors. Cancer Treat Rev. 2015;41:623\u201333.","journal-title":"Cancer Treat Rev"},{"key":"388_CR11","doi-asserted-by":"crossref","first-page":"20702","DOI":"10.1074\/jbc.R115.648691","volume":"290","author":"S Martinez","year":"2015","unstructured":"Martinez S, Hausinger RP. Catalytic mechanisms of Fe(II)- and 2-Oxoglutarate-dependent Oxygenases. J Biol Chem. 2015;290:20702\u201311.","journal-title":"J Biol Chem"},{"key":"388_CR12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0006-291X(78)91010-0","volume":"28","author":"R Myllyl\u00e4","year":"1978","unstructured":"Myllyl\u00e4 R, Kuutti-Savolainen ER, Kivirikko KI. The role of ascorbate in the prolyl hydroxylase reaction. Biochem Biophys Res Commun. 1978;28:441\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"388_CR13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/toxsci\/kfn251","volume":"107","author":"M Kaczmarek","year":"2009","unstructured":"Kaczmarek M, Cachau RE, Topol IA, Kasprzak KS, Ghio A, Salnikow K. Metal ions-stimulated iron oxidation in hydroxylases facilitates stabilization of HIF-1 alpha protein. Toxicol Sci. 2009;107:394\u2013403.","journal-title":"Toxicol Sci"},{"key":"388_CR14","doi-asserted-by":"crossref","first-page":"11105","DOI":"10.1073\/pnas.0804226105","volume":"105","author":"Q Chen","year":"2008","unstructured":"Chen Q, Espey MG, Sun AY, et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A. 2008;105:11105\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"388_CR15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00280-013-2070-8","volume":"71","author":"LJ Welsh","year":"2013","unstructured":"Welsh LJ, Wagner BA, van\u2019t Erve TJ, et al. Pharmacological Ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol. 2013;71:765\u201375.","journal-title":"Cancer Chemother Pharmacol"},{"key":"388_CR16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.freeradbiomed.2009.02.016","volume":"47","author":"J Verrax","year":"2009","unstructured":"Verrax J, Calderon PB. Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects. Free Radic Biol Med. 2009;47:32\u201340.","journal-title":"Free Radic Biol Med"},{"key":"388_CR17","doi-asserted-by":"crossref","first-page":"23706","DOI":"10.1074\/jbc.270.40.23706","volume":"270","author":"JC Vera","year":"1995","unstructured":"Vera JC, Rivas CI, Vel\u00e1squez FV, Zhang RH, Concha II, Golde DW. Resolution of the facilitated transport of dehydroascorbic acid from its intracellular accumulation as ascorbic acid. J Biol Chem. 1995;270:23706\u201312.","journal-title":"J Biol Chem"},{"key":"388_CR18","doi-asserted-by":"crossref","unstructured":"Savini I, Rossi A, Pierro C, Avigliano L, Catani MV. SVCT1 and SVCT2: key proteins for vitamin C uptake. Amino Acids 2008; 34: 347\u2013355.","DOI":"10.1007\/s00726-007-0555-7"},{"key":"388_CR19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrm2455","volume":"9","author":"M Sch\u00e4fer","year":"2008","unstructured":"Sch\u00e4fer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol. 2008;9:628\u201338.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"388_CR20","first-page":"4555","volume":"59","author":"DB Agus","year":"1999","unstructured":"Agus DB, Vera JC, Golde DW. Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. Cancer Res. 1999;59:4555\u20138.","journal-title":"Cancer Res"},{"key":"388_CR21","doi-asserted-by":"crossref","first-page":"18982","DOI":"10.1074\/jbc.272.30.18982","volume":"272","author":"SC Rumsey","year":"1997","unstructured":"Rumsey SC, Kwon O, Xu GW, Burant CF, Simpson I . Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem 1997; 272: 18982\u201318989.","journal-title":"J Biol Chem"},{"key":"388_CR22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3892\/mmr.2012.969","volume":"6","author":"P J\u00f3\u017awiak","year":"2012","unstructured":"J\u00f3\u017awiak P, Krze\u015blak A, Pomorski L, Lipi\u0144ska A. Expression of hypoxia-related glucose transporters GLUT1 and GLUT3 in benign, malignant and non-neoplastic thyroid lesions. Mol Med Rep. 2012;6:601\u20136.","journal-title":"Mol Med Rep"},{"key":"388_CR23","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1080\/01635581.2015.1078823","volume":"67","author":"P J\u00f3\u017awiak","year":"2015","unstructured":"J\u00f3\u017awiak P, Krze\u015blak A, Wieczorek M, Lipi\u0144ska A. Effect of glucose on GLUT1-dependent intracellular Ascorbate accumulation and viability of thyroid cancer cells. Nutr Cancer. 2015;67:1333\u201341.","journal-title":"Nutr Cancer"},{"key":"388_CR24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/abio.2000.4592","volume":"282","author":"J Lykkesfeldt","year":"2000","unstructured":"Lykkesfeldt J. Determination of ascorbic acid and dehydroascorbic acid in biological samples by high-performance liquid chromatography using subtraction methods: reliable reduction with tris[2-carboxyethyl]phosphine hydrochloride. Anal Biochem. 2000;282:89\u201393.","journal-title":"Anal Biochem"},{"key":"388_CR25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.vph.2012.02.006","volume":"56","author":"A Loboda","year":"2012","unstructured":"Loboda A, Jozkowicz A, Dulak J. HIF-1 versus HIF-2 is one more important than the other? Vasc Pharmacol. 2012;56:245\u201351.","journal-title":"Vasc Pharmacol"},{"key":"388_CR26","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1158\/0008-5472.CAN-10-4142","volume":"71","author":"MY Koh","year":"2011","unstructured":"Koh MY, Lemos R, Liu X, Powis G. The hypoxia-associated factor switches cells from HIF-1\u03b1- to HIF-2\u03b1-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion. Cancer Res. 2011;71:4015\u201327.","journal-title":"Cancer Res"},{"key":"388_CR27","doi-asserted-by":"crossref","first-page":"e0125771","DOI":"10.1371\/journal.pone.0125771","volume":"10","author":"S P\u00e5hlman","year":"2015","unstructured":"P\u00e5hlman S, Lund LR, J\u00f6gi A. Differential HIF-1\u03b1 and HIF-2\u03b1 expression in mammary epithelial cells during fat pad invasion, lactation, and involution. PLoS One. 2015;10:e0125771.","journal-title":"PLoS One"},{"key":"388_CR28","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.3892\/ol.2015.3545","volume":"10","author":"N Abd-Aziz","year":"2015","unstructured":"Abd-Aziz N, Stanbridge EJ, Shafee N. Bortezomib attenuates HIF-1- but not HIF-2-mediated transcriptional activation. Oncol Lett. 2015;10:2192\u20136.","journal-title":"Oncol Lett"},{"key":"388_CR29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1677\/ERC-08-0251","volume":"17","author":"N Burrows","year":"2010","unstructured":"Burrows N, Resch J, Cowen RL, et al. Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas. Endocr Relat Cancer. 2010;17:61\u201372.","journal-title":"Endocr Relat Cancer"},{"key":"388_CR30","first-page":"322","volume":"7","author":"N Wang","year":"2013","unstructured":"Wang N, Dong CR, Jiang R, et al. Overexpression of HIF-1\u03b1, metallothionein and SLUG is associated with high TNM stage and lymph node metastasis in papillary thyroid carcinoma. Int J Clin Exp Pathol. 2013;7:322\u201330.","journal-title":"Int J Clin Exp Pathol"},{"key":"388_CR31","doi-asserted-by":"crossref","unstructured":"Wang N, Luo HJ, Yin GB, et al. Overexpression of HIF-2\u03b1, TWIST, and CXCR4 is associated with lymph node metastasis in papillary thyroid carcinoma. Clin Dev Immunol. 2013:589423.","DOI":"10.1155\/2013\/589423"},{"key":"388_CR32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.freeradbiomed.2014.01.033","volume":"69","author":"C Kuiper","year":"2014","unstructured":"Kuiper C, Dachs GU, Currie MJ, Vissers MC. Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response. Free Radic Biol Med. 2014;69:308\u201317.","journal-title":"Free Radic Biol Med"},{"key":"388_CR33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.freeradbiomed.2006.11.023","volume":"42","author":"MC Vissers","year":"2007","unstructured":"Vissers MC, Gunningham SP, Morrison MJ, Dachs GU, Currie MJ. Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate. Free Radic Biol Med. 2007;42:765\u201372.","journal-title":"Free Radic Biol Med"},{"key":"388_CR34","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.freeradbiomed.2007.01.026","volume":"42","author":"M Kaczmarek","year":"2007","unstructured":"Kaczmarek M, Timofeeva OA, Karaczyn A, Malyguine A, Kasprzak KS, Salnikow K. The role of ascorbate in the modulation of HIF-1alpha protein and HIF-dependent transcription by chromium(VI) and nickel(II). Free Radic Biol Med. 2007;42:1246\u201357.","journal-title":"Free Radic Biol Med"},{"key":"388_CR35","first-page":"16","volume":"57","author":"H Dudek","year":"2004","unstructured":"Dudek H, Farbiszewski R, Rydzewska M, Michno T, Koz\u0142owski A. Evaluation of antioxidant enzymes activity and concentration of non-enzymatic antioxidants in human brain tumours. Wiad Lek. 2004;57:16\u20139.","journal-title":"Wiad Lek"},{"key":"388_CR36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/15287390152543690","volume":"64","author":"E Skrzydlewska","year":"2001","unstructured":"Skrzydlewska E, Stankiewicz A, Sulkowska M, Sulkowski S, Kasacka I. Antioxidant status and lipid peroxidation in colorectal cancer. J Toxicol Environ Health A. 2001;64:213\u201322.","journal-title":"J Toxicol Environ Health A"},{"key":"388_CR37","first-page":"361","volume":"9","author":"AI Fiaschi","year":"2005","unstructured":"Fiaschi AI, Cozzolino A, Ruggiero G, Giorgi G. Glutathione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 2005;9:361\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"388_CR38","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/bjc.1982.211","volume":"46","author":"HM Anthony","year":"1982","unstructured":"Anthony HM, Schorah CJ. Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance. Br J Cancer. 1982;46:354\u20137.","journal-title":"Br J Cancer"},{"key":"388_CR39","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/ijc.2910430634","volume":"43","author":"H Langemann","year":"1989","unstructured":"Langemann H, Torhorst J, Kabiersch A, Krenger W, Honegger CG. Quantitative determination of water- and lipid-soluble antioxidants in neoplastic and non-neoplastic human breast tissue. Int J Cancer. 1989;43:1169\u201373.","journal-title":"Int J Cancer"},{"key":"388_CR40","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1158\/0008-5472.CAN-10-0263","volume":"70","author":"C Kuiper","year":"2010","unstructured":"Kuiper C, Molenaar IG, Dachs GU, Currie MJ, Sykes PH, Vissers MC. Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer. Cancer Res. 2010;70:5749\u201358.","journal-title":"Cancer Res"},{"key":"388_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fonc.2014.00010","volume":"4","author":"C Kuiper","year":"2014","unstructured":"Kuiper C, Dachs GU, Munn D, Currie MJ, Robinson BA, Pearson JF, Vissers MC. Increased tumor Ascorbate is associated with extended disease-free survival and decreased hypoxia-inducible Factor-1 activation in human colorectal cancer. Front Oncol. 2014;4:10. doi 10.3389\/fonc.2014.00010 .","journal-title":"Front Oncol"},{"key":"388_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00359","volume":"4","author":"C Kuiper","year":"2014","unstructured":"Kuiper C, Vissers MC. Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression. Front Oncol. 2014;4:359. doi: 10.3389\/fonc.2014.00359 .","journal-title":"Front Oncol"},{"key":"388_CR43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.abb.2010.05.014","volume":"500","author":"A Corti","year":"2010","unstructured":"Corti A, Casini AF, Pompella A. Cellular pathways for transport and efflux of ascorbate and dehydroascorbate. Arch Biochem Biophys. 2010;500:107\u201315.","journal-title":"Arch Biochem Biophys"},{"key":"388_CR44","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.mehy.2013.07.023","volume":"81","author":"MF McCarty","year":"2013","unstructured":"McCarty MF. Expression and\/or activity of the SVCT2 ascorbate transporter may be decreased in many aggressive cancers, suggesting potential utility for sodium bicarbonate and dehydroascorbic acid in cancer therapy. Med Hypotheses. 2013;81:664\u201370.","journal-title":"Med Hypotheses"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-017-0388-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T06:01:25Z","timestamp":1570255285000},"score":1,"resource":{"primary":{"URL":"http:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-017-0388-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,30]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["388"],"URL":"https:\/\/doi.org\/10.1186\/s12929-017-0388-y","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,30]]},"article-number":"83"}}